Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Kodiak Sciences Inc.
Market Cap
$5.78B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.79B
Net Profit Margin
-89.09%
TTM Avg
-187.61%
3Y Avg
-9430.16%
5Y Avg
-6286.77%
Market Cap
$5.87B
Net Profit Margin
9.59%
TTM Avg
-0.75%
3Y Avg
21.75%
5Y Avg
-53.79%
Market Cap
$5.89B
Net Profit Margin
-236.95%
TTM Avg
-945.70%
3Y Avg
-3296.24%
5Y Avg
-3620.73%
Market Cap
$5.61B
Net Profit Margin
-3602.68%
TTM Avg
-5857.26%
3Y Avg
-13524.50%
5Y Avg
-10844.39%
Market Cap
$5.95B
Net Profit Margin
67.88%
TTM Avg
22.01%
3Y Avg
16.68%
5Y Avg
14.76%
Market Cap
$5.52B
Net Profit Margin
-10.21%
TTM Avg
-9.94%
3Y Avg
-7.18%
5Y Avg
-7.18%
Market Cap
$6.23B
Net Profit Margin
-85.59%
TTM Avg
-151.92%
3Y Avg
-327.14%
5Y Avg
-585.95%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.78B | 0.00% | 0.00% | 0.00% | 0.00% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -89.09% | -187.61% | -9430.16% | -6286.77% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 9.59% | -0.75% | 21.75% | -53.79% |
| GRAIL Inc. (GRAL)vs › | $5.89B | -236.95% | -945.70% | -3296.24% | -3620.73% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -3602.68% | -5857.26% | -13524.50% | -10844.39% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 67.88% | 22.01% | 16.68% | 14.76% |
| RadNet, Inc. (RDNT)vs › | $5.53B | -0.93% | -0.38% | 0.04% | 0.11% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | -10.21% | -9.94% | -7.18% | -7.18% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | -85.59% | -151.92% | -327.14% | -585.95% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | -3.80% | -2.80% | -38.10% | -60.79% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
